Symrise AG, a global leader within the consolidated flavors and fragrances industry, is undergoing a significant cyclical inflection point. While adverse market dynamics in 2025—ranging from demand slowdowns to pronounced destocking and foreign exchange headwinds—have led to lower growth guidance and share price underperformance, the company's operational discipline is preserving core profitability. The group continues to overdeliver on margin through targeted efficiency programs and a strategic emphasis on high-value segments like Pet Food and Cosmetic Ingredients. With current valuation at multi-year lows, there is evidence that the market is overly discounting temporary cyclical weaknesses versus structural strengths inherent in Symrise's premium business model. The investment outlook hinges on successful divestment of non-core assets and improvement in US-EU trade policy volatility, with upside potential as the market regains confidence in the company’s normalized growth and profit trajectory.